Disc Medicine, Inc. Basic Shares Outstanding (Weighted Average)
Disc Medicine, Inc. (IRON) reported Basic Shares Outstanding (Weighted Average) of 38.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 38.69M shares, a 10.45% increase year-over-year.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 38.49M shares, a 15.50% increase year-over-year.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 37.63M shares, a 25.47% increase year-over-year.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 35.18M shares, a 17.51% increase year-over-year.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 35.30M shares, a 27.85% increase from fiscal 2024.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 27.61M shares, a 23.71% increase from fiscal 2023.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 22.32M shares, a 2046.81% increase from fiscal 2022.
- Disc Medicine, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 1.04M shares, a 18.34% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 38.69M shares 10-Q · filed 2026-07-30 | 38.59M shares 10-Q · filed 2026-07-30 | 38.27M shares derived: average of 3 quarters · filed 2026-07-30 | 37.50M shares derived: average of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | 38.49M shares 10-Q · filed 2026-05-05 | 38.06M shares derived: average of 2 quarters · filed 2026-05-05 | 37.10M shares derived: average of 3 quarters · filed 2026-05-05 | 36.58M shares derived: average of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | 37.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 36.41M shares derived: average of 2 quarters · filed 2026-02-26 | 35.95M shares derived: average of 3 quarters · filed 2026-07-30 | 35.30M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 35.18M shares 10-Q · filed 2025-11-06 | 35.10M shares derived: average of 2 quarters · filed 2026-07-30 | 34.52M shares 10-Q · filed 2025-11-06 | 33.38M shares derived: average of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | 35.02M shares 10-Q · filed 2026-07-30 | 34.18M shares 10-Q · filed 2026-07-30 | 32.78M shares derived: average of 3 quarters · filed 2026-07-30 | 32.07M shares derived: average of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | 33.32M shares 10-Q · filed 2026-05-05 | 31.66M shares derived: average of 2 quarters · filed 2026-05-05 | 31.09M shares derived: average of 3 quarters · filed 2026-05-05 | 29.73M shares derived: average of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | 30.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 29.97M shares derived: average of 2 quarters · filed 2026-02-26 | 28.53M shares derived: average of 3 quarters · filed 2026-02-26 | 27.61M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 29.94M shares 10-Q · filed 2025-11-06 | 27.79M shares derived: average of 2 quarters · filed 2025-11-06 | 26.81M shares 10-Q · filed 2025-11-06 | 26.21M shares derived: average of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | 25.65M shares 10-Q · filed 2025-08-07 | 25.23M shares 10-Q · filed 2025-08-07 | 24.97M shares derived: average of 3 quarters · filed 2026-02-26 | 24.81M shares derived: average of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | 24.81M shares 10-Q · filed 2025-05-07 | 24.63M shares derived: average of 2 quarters · filed 2026-02-26 | 24.52M shares derived: average of 3 quarters · filed 2026-02-26 | 23.76M shares derived: average of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | 24.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 24.38M shares derived: average of 2 quarters · filed 2026-02-26 | 23.42M shares derived: average of 3 quarters · filed 2026-02-26 | 22.32M shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 24.32M shares 10-Q · filed 2024-11-12 | 22.90M shares derived: average of 2 quarters · filed 2024-11-12 | 21.61M shares 10-Q · filed 2024-11-12 | 16.52M shares derived: average of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | 21.48M shares 10-Q · filed 2024-08-08 | 20.23M shares 10-Q · filed 2024-08-08 | 13.92M shares derived: average of 3 quarters · filed 2024-08-08 | 10.68M shares derived: average of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | 18.95M shares 10-Q · filed 2024-05-09 | 10.14M shares derived: average of 2 quarters · filed 2024-05-09 | 7.08M shares derived: average of 3 quarters · filed 2024-05-09 | 5.55M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 1.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 1.14M shares derived: average of 2 quarters · filed 2024-03-21 | 1.08M shares derived: average of 3 quarters · filed 2024-03-21 | 1.04M shares 10-K · filed 2024-03-21 | |||
| 2022-09-30 | 960.32K shares 10-Q · filed 2023-11-09 | 43.26M shares 10-Q · filed 2022-11-10 | 952.51K shares derived: average of 2 quarters · filed 2023-11-09 | 943.06K shares 10-Q · filed 2023-11-09 | 43.24M shares 10-Q · filed 2022-11-10 | -27.99M shares derived: average of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | 944.71K shares 10-Q · filed 2023-08-11 | 43.23M shares 10-Q · filed 2022-08-11 | 934.29K shares 10-Q · filed 2023-08-11 | 43.22M shares 10-Q · filed 2022-08-11 | -37.63M shares derived: average of 3 quarters · filed 2023-08-11 | -17.45M shares derived: average of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | 923.75K shares 10-Q · filed 2023-05-15 | -56.92M shares derived: average of 2 quarters · filed 2023-05-15 | -23.58M shares derived: average of 3 quarters · filed 2023-05-15 | -6.93M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -114.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -35.84M shares derived: average of 2 quarters · filed 2023-03-31 | -9.55M shares derived: average of 3 quarters · filed 2023-03-31 | 878.41K shares 10-K · filed 2023-03-31 | |||
| 2021-09-30 | 43.09M shares 10-Q · filed 2022-11-10 | 43.07M shares derived: average of 2 quarters · filed 2022-11-10 | 39.43M shares 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | 43.04M shares 10-Q · filed 2022-08-11 | 37.56M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |